Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
Science (New York, N.Y.)
|
November 15, 2008
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer
Sooryanarayana Varambally, Qi Cao, Ram-Shankar Mani, et al.
Nature Communications
|
March 28, 2026
FOXA1 loss drives basal/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment
Lourdes Brea, Hongshun Shi, Viriya Keo, et al.
Cancer Research
|
April 6, 2007
Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma
Guoan Chen, Xiaoju Wang, Jianjun Yu, et al.
Nature
|
August 3, 2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A Tomlins, Bharathi Laxman, Saravana M Dhanasekaran, et al.
Oncogene
|
January 7, 2026
EZH2 PROTACs outperform catalytic inhibitors in prostate cancer by targeting a methylation-independent function of PRC2
Wanqing Xie, Qi Chu, Lourdes Brea, et al.
Genome Research
|
July 5, 2011
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer
Jung H Kim, Saravana M Dhanasekaran, John R Prensner, et al.
Cancer Cell
|
May 19, 2010
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
Jindan Yu, Jianjun Yu, Ram-Shankar Mani, et al.
Cancer Cell
|
August 16, 2011
Coordinated regulation of polycomb group complexes through microRNAs in cancer
Qi Cao, Ram-Shankar Mani, Bushra Ateeq, et al.
Nature
|
February 13, 2009
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, et al.
Cell
|
July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Qianben Wang, Wei Li, Yong Zhang, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
Science (New York, N.Y.)
|
November 15, 2008
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer
Sooryanarayana Varambally, Qi Cao, Ram-Shankar Mani, et al.
Nature Communications
|
March 28, 2026
FOXA1 loss drives basal/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment
Lourdes Brea, Hongshun Shi, Viriya Keo, et al.
Cancer Research
|
April 6, 2007
Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma
Guoan Chen, Xiaoju Wang, Jianjun Yu, et al.
Nature
|
August 3, 2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A Tomlins, Bharathi Laxman, Saravana M Dhanasekaran, et al.
Oncogene
|
January 7, 2026
EZH2 PROTACs outperform catalytic inhibitors in prostate cancer by targeting a methylation-independent function of PRC2
Wanqing Xie, Qi Chu, Lourdes Brea, et al.
Genome Research
|
July 5, 2011
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer
Jung H Kim, Saravana M Dhanasekaran, John R Prensner, et al.
Cancer Cell
|
May 19, 2010
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
Jindan Yu, Jianjun Yu, Ram-Shankar Mani, et al.
Cancer Cell
|
August 16, 2011
Coordinated regulation of polycomb group complexes through microRNAs in cancer
Qi Cao, Ram-Shankar Mani, Bushra Ateeq, et al.
Nature
|
February 13, 2009
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila M Poisson, Thekkelnaycke M Rajendiran, et al.
Cell
|
July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Qianben Wang, Wei Li, Yong Zhang, et al.
Page
of 13